Indigo Pharmaceuticals, Inc. Appoints Dennis R. Cryer as Chief Medical Officer

Published: Oct 09, 2007

NEW YORK, Oct. 9, 2007 (PRIME NEWSWIRE) -- Manhattan-based Indigo Pharmaceuticals, Inc., a Paramount Biosciences-founded company committed to the development of new treatments for patients living with cardiovascular diseases and currently concentrating on peripheral arterial disease, announced today that Dennis R. Cryer, MD, FAHA has joined the company as its Chief Medical Officer. Dr. Cryer leaves a position as Vice President, External Medical Affairs at Bristol-Myers Squibb to lead clinical programs for Indigo Pharmaceuticals.

Back to news